FIELD: medicine.
SUBSTANCE: histochemical study of the primary tumour preparations is conducted, and a histogenetic type of breast cancer is determined. Additionally, a distribution pattern of the receptor to oestrogen expression is described as follows: homogeneous one in the uniform, only severe, only moderate or only mild expression, heterogeneous one - in various combinations of the severe, moderate or mild expression, and negative one, with taking into account the stage of the process and the extent of a surgery performed. A regression value in a surgical scar is calculated by the presented formula.
EFFECT: higher accuracy and information value of the prediction procedure.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF OCCURRENCE OF LOCAL RECURRENCES IN POSTOPERATIVE PERIOD IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER | 2020 |
|
RU2734719C1 |
| METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANIED BY INVASIVE NONSPECIFIC TRIPLE-NEGATIVE BREAST CANCER | 2014 |
|
RU2558860C1 |
| METHOD FOR PREDICTION OF HAEMATOGENOUS METASTASIS IN TRIPLE NEGATIVE INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2558863C1 |
| METHOD FOR PREDICTING RISK OF BREAST CANCER PROGRESSION WITH UNDERLYING TAMOXIFEN TAKING INTO ACCOUNT EXPRESSION CHARACTERISTICS OF TUMOUR | 2023 |
|
RU2823488C1 |
| METHOD FOR PREDICTION OF ANTI-OESTROGEN TAMOXIFEN THERAPY EFFECTIVENESS IN PATIENTS WITH LUMINAL BREAST CANCER | 2014 |
|
RU2558857C1 |
| METHOD OF PREDICTING EFFICIENCY OF NEOADJUVANT CHEMICAL THERAPY IN PATIENTS WITH RESECTABLE BASAL-LIKE TRIPLE-NEGATIVE BREAST CANCER | 2013 |
|
RU2538638C1 |
| METHOD FOR PREDICTION OF DEGREE OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LUMINAL MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2632112C1 |
| METHOD OF PREDICTING ACHIEVEMENT OF COMPLETE MORPHOLOGICAL REGRESSIONS IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER, WHO OBTAINED CHEMOTHERAPY COURSES IN CAX REGIMEN | 2014 |
|
RU2563180C1 |
| METHOD FOR PREDICTION OF COMPLETE MORPHOLOGICAL REGRESSIONS IN PATIENTS SUFFERING TRIPLE-NEGATIVE RESECTABLE BREAST CANCER | 2014 |
|
RU2560707C1 |
| METHOD FOR PREDICTION OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH THREE-TIMES NEGATIVE MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2623118C1 |
